222 related articles for article (PubMed ID: 34830620)
1. Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe.
Dziedzic A; Riad A; Attia S; Klugar M; Tanasiewicz M
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830620
[TBL] [Abstract][Full Text] [Related]
2. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers.
Klugar M; Riad A; Mekhemar M; Conrad J; Buchbender M; Howaldt HP; Attia S
Biology (Basel); 2021 Aug; 10(8):. PubMed ID: 34439984
[TBL] [Abstract][Full Text] [Related]
3. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
[TBL] [Abstract][Full Text] [Related]
4. Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA.
Riad A; Alsaad SS; Almurikhi AA; Alzahrani FA; Alghamdi AM; Alzaid EH; Klugar M
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560547
[TBL] [Abstract][Full Text] [Related]
5. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
6. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.
Yesuf EA; Riad A; Sofi-Mahmudi A; Sudhakar M; Mekonnen A; Endalkachew S; Mama F; Muhidin S; Ayele B; Yahya M; Usman A; Abafita J; Klugar M
Front Public Health; 2022; 10():937794. PubMed ID: 35928493
[TBL] [Abstract][Full Text] [Related]
7. Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.
Raethke M; van Hunsel F; Thurin NH; Dureau-Pournin C; Mentzer D; Kovačić B; Mirošević Skvrce N; De Clercq E; Sabbe M; Trifirò G; Luxi N; Giovanazzi A; Shakir S; Klungel OH; Schmikli S; Sturkenboom M
Drug Saf; 2023 Apr; 46(4):391-404. PubMed ID: 37024736
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
Maruyama A; Sawa T; Teramukai S; Katoh N
J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
[TBL] [Abstract][Full Text] [Related]
9. Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
Malden DE; Gee J; Glenn S; Li Z; Mercado C; Ogun OA; Kim S; Lewin BJ; Ackerson BK; Jazwa A; Weintraub ES; McNeil MM; Tartof SY
Vaccine; 2023 Jan; 41(2):315-322. PubMed ID: 36351861
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study.
Ripabelli G; Tamburro M; Buccieri N; Adesso C; Caggiano V; Cannizzaro F; Di Palma MA; Mantuano G; Montemitro VG; Natale A; Rodio L; Sammarco ML
J Community Health; 2022 Apr; 47(2):211-225. PubMed ID: 34628568
[TBL] [Abstract][Full Text] [Related]
11. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic.
Riad A; Pokorná A; Attia S; Klugarová J; Koščík M; Klugar M
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916020
[TBL] [Abstract][Full Text] [Related]
14. Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia.
Abera BT; Teka H; Berhe E; Gebru MA; Zenebe D; Abraha HE; Hailu A
Sci Rep; 2024 Feb; 14(1):3255. PubMed ID: 38332047
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
17. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.
Rosenblum HG; Gee J; Liu R; Marquez PL; Zhang B; Strid P; Abara WE; McNeil MM; Myers TR; Hause AM; Su JR; Markowitz LE; Shimabukuro TT; Shay DK
Lancet Infect Dis; 2022 Jun; 22(6):802-812. PubMed ID: 35271805
[TBL] [Abstract][Full Text] [Related]
18. Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers.
Kałucka S; Kusideł E; Głowacka A; Oczoś P; Grzegorczyk-Karolak I
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335033
[TBL] [Abstract][Full Text] [Related]
19. Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
Al-Obaydi S; Hennrikus E; Mohammad N; Lehman EB; Thakur A; Al-Shaikhly T
PLoS One; 2022; 17(8):e0272691. PubMed ID: 35930586
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]